Atlas Trials

Rokote Laboratories Finland Oy

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Rokote Laboratories Finland Oy

RecordFirmDate
Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19 (NCT07416539)Rokote Laboratories Finland Oy2026-02-10
The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus (NCT06851611)Rokote Laboratories Finland Oy2025-01-21

Track Rokote Laboratories Finland Oy automatically

Every clearance here is in the API, with alerts when new ones post.